Uterine cancer in Jewish Israeli <i>BRCA1/2</i> mutation carriers

Abstract

Israeli BRCA1 or BRCA2 mutation carriers are at an increased risk for developing uterine cancer, especially serous papillary and sarcoma. These elevated risks of uterine cancer should be discussed with BRCA carriers.